Pore-forming toxins (PFT) form the largest family of secreted toxins from pathogenic bacteria.[@R1]^,^[@R2] *Staphylococcus aureus* produces different hemolysins, and α-hemolysin is one of the well-studied PFTs for which the X-ray structure of the pore is available.[@R1] These toxins form heptameric pores of 1--2 nm in size in cell membranes, leading to various outcomes, including apoptotic cell death, in the host cells.[@R2] As epithelial cells and keratinocytes are the major sites of pathogen entry, we have set out to investigate the molecular machinery driving cell death mediated by α-hemolysin in these cell types. To our surprise, we have detected an initiator caspase role for caspase-2 during PFT-mediated apoptosis, and further investigations revealed that caspase-2 is activated in a PIDDosome-independent manner under these conditions.[@R3]

Caspases are effector proteases of the apoptotic cascade and broadly divided into two major classes depending on the structure and chronology of their activation as initiator and effector caspases.[@R4] Despite being the first mammalian caspases to be cloned and highly conserved, the physiological role of this caspase remains unclear.[@R5]^,^[@R6] Caspase-2-deficient mice develop normally, with mild defects, and emerging evidence suggests a role for this caspase in regulating DNA damage response, cell cycle regulation and tumor suppression.[@R6] Like other initiator caspases, caspase-2 is activated by dimerization mediated through the CARD domains, and initial studies revealed that caspase-2 is recruited to a high molecular weight complex distinct from the apoptosome in cell lysates upon transfer from 4°C to 37°C.[@R7] During genotoxic stress, caspase-2 has been shown to be recruited to a multimeric protein complex, PIDDosome, constituting a Death Domain (DD)-containing PIDD (P53-induced protein with death domain) and a DD and CARD domain-containing adaptor protein RAIDD (RIP-associated ICH-1/CED-3 homologous protein with death domain).[@R8] However, recent studies reveal that caspase-2 can be activated in the absence of PIDDosome, which warrants for the presence of additional caspase-2 activation platforms.[@R9] However, whether such caspase-2 complexes are formed in apoptotic cells and the unique apoptotic stimuli where caspase-2 is activated as an initiator caspase remain unclear.

By exploiting an "in situ caspase trapping" approach employing biotin-VAD, we identified that caspase-2, but not caspase-8 or caspase-9, is precipitated as a proximal caspase during PFT-mediated apoptosis in HeLa cells.[@R3] Consistently, loss of caspase-2 prevented PFT-mediated apoptosis in HeLa cells and mouse embryonic fibroblasts. Interestingly, loss of either PIDD or RAIDD has failed to render protection to PFT-mediated apoptosis, and caspase-2 is activated in RAIDD-deficient cells. Caspase-2 is activated in caspase-3/7 DKO MEFs, suggesting that the activation and processing of caspase-2 under these settings is independent of effector caspases.

Intriguingly, PFT-mediated cell death is partially inhibited by loss of Bax and Bak, the major regulators of the mitochondrial outer membrane permeabilization or by the loss of effector caspases 3 and 7 ([Fig. 1](#F1){ref-type="fig"}). It is currently unclear how caspase-2 accomplishes Bax/Bak activation, and further, it is tempting to propose that caspase-2 might forgo the loss of these two effector caspases and cleave the relevant substrates directly to accomplish cell death ([Fig. 1](#F1){ref-type="fig"}). Recent studies employing N-terminal COFRADIC (combined fractional diagonal chromatography) to study the degradome of caspases revealed that the protease specificities of caspase-2 largely overlap with the effector caspases.[@R10] By applying Bimolecular Fluorescence Complementation (BiFc), we have checked for the intracellular localization of dimerized caspase-2-CARD domains in toxin-treated cells. Consistent with Bouchier-Hayes et al., we have detected a cytosolic staining of caspase-2-CARD-BiFc signals in HeLa cells after treatment with α-toxin.[@R3]^,^[@R11] The BiFc signals for caspase-2-CARD domain exhibited a punctuate staining under these settings.[@R3]

![**Figure 1.** Pore-forming toxins induce various forms of cell death depending on the cell type and the extent of toxin insult. In epithelial cells, caspase-2 is activated as an initiator caspase in a PIDDosome-independent manner to regulate PFT-mediated cell death. The PFT-mediated cell death is partially dependent on Bax and Bak as well as on effector caspases, revealing that caspase-2 might also exhibit features of effector caspases. Activation of caspase-2 has been shown to be regulated by PP1, 14-3-3 zeta and PKCK2 under various settings, and it would be interesting to characterize if caspases-2 phosphorylation regulates its activation in response to PFTs.](cc-11-3709-g1){#F1}

By employing high-resolution gel filtration chromatography, we detected that caspase-2 is consistently detected in a high molecular weight fraction larger than a single ribosome (approx. 3 MDa) in the toxin-treated cells. This complex is devoid of RAIDD or PIDD, and we detect either the full-length or the processed fragments of caspase-2 in this high molecular weight complex in the apoptotic cells. Detection of full-length caspase-2 to this HMW complex suggests that caspase-2 is possibly recruited to this complex for its activation during PFT-mediated apoptosis in these cell types.

Previous studies revealed that PFTs induce K^+^ efflux in the cells, leading to various outcomes ranging from inflammasome activation to pyroptosis to autophagy depending on the cell type and the extent of the toxin insult ([Fig. 1](#F1){ref-type="fig"}). As expected, inhibition of PFT-mediated K^+^ efflux prevented the recruitment and activation of caspase-2 to the HMW complex, thus preventing cell death. Further, physiological concentrations of K^+^ and Na^+^ ions have been shown to prevent the assemblage of apoptosome as well as the activation of caspase-2 in cell-free systems.[@R7]^,^[@R12] Whether reduction in the physiological concentrations of K^+^ ions upon toxin treatment spontaneously led to the direct dimerization of caspase-2 needs further studies. Further, it is currently unclear if there is a concurrent increase in the intracellular calcium ion concentrations upon toxin treatment, and if there is any role for Ca^2+^ influx in mediating caspase-2 activation in these cell types.

Interestingly, caspase-2 is regulated by phosphorylation under various settings, and it would be interesting to test if phosphorylation/dephosphorylation events regulate the activation of caspase-2 upon PFT treatment.[@R5] In conclusion, our studies reveal unique apoptotic stimuli where caspases-2 is activated as an initiator caspase to mediate apoptotic cell death in non-lymphoid cells. These observations possibly open up new avenues to decipher potential PIDDosome-independent caspase-2 activation platforms.
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